Your browser doesn't support javascript.
loading
Data quality at the Singapore Cancer Registry: An overview of comparability, completeness, validity and timeliness.
Fung, Janice Wing Mei; Lim, Sandra Bee Lay; Zheng, Huili; Ho, William Ying Tat; Lee, Bee Guat; Chow, Khuan Yew; Lee, Hin Peng.
Afiliação
  • Fung JW; National Registry of Diseases Office, Singapore Cancer Registry, Health Promotion Board, 3 Second Hospital Avenue, Singapore 168937, Singapore. Electronic address: janice_fung@hpb.gov.sg.
  • Lim SB; National Registry of Diseases Office, Singapore Cancer Registry, Health Promotion Board, 3 Second Hospital Avenue, Singapore 168937, Singapore.
  • Zheng H; National Registry of Diseases Office, Singapore Cancer Registry, Health Promotion Board, 3 Second Hospital Avenue, Singapore 168937, Singapore.
  • Ho WY; National Registry of Diseases Office, Singapore Cancer Registry, Health Promotion Board, 3 Second Hospital Avenue, Singapore 168937, Singapore.
  • Lee BG; National Registry of Diseases Office, Singapore Cancer Registry, Health Promotion Board, 3 Second Hospital Avenue, Singapore 168937, Singapore.
  • Chow KY; National Registry of Diseases Office, Singapore Cancer Registry, Health Promotion Board, 3 Second Hospital Avenue, Singapore 168937, Singapore.
  • Lee HP; Saw Swee Hock School of Public Health, National University of Singapore, 12 Science Drive 2 #10-01 Singapore 117549, Singapore.
Cancer Epidemiol ; 43: 76-86, 2016 08.
Article em En | MEDLINE | ID: mdl-27399312
ABSTRACT

AIM:

To provide a comprehensive evaluation of the quality of the data at the Singapore Cancer Registry (SCR).

METHODS:

Quantitative and semi-quantitative methods were used to assess the comparability, completeness, accuracy and timeliness of data for the period of 1968-2013, with focus on the period 2008-2012.

RESULTS:

The SCR coding and classification systems follow international standards. The overall completeness was estimated at 98.1% using the flow method and 97.5% using the capture-recapture method, for the period of 2008-2012. For the same period, 91.9% of the cases were morphologically verified (site-specific range 40.4-100%) with 1.1% DCO cases. The under-reporting in 2011 and 2012 due to timely publication was estimated at 0.03% and 0.51% respectively.

CONCLUSION:

This review shows that the processes in place at the SCR yields data which are internationally comparable, relatively complete, valid, and timely, allowing for greater confidence in the use of quality data in the areas of cancer prevention, treatment and control.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistema de Registros / Reprodutibilidade dos Testes / Neoplasias Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistema de Registros / Reprodutibilidade dos Testes / Neoplasias Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2016 Tipo de documento: Article